Results: 26-50/6233
Authors:
Broek, IV
Vanderkerken, K
De Greef, C
Asosingh, K
Straetmans, N
Van Camp, B
Van Riet, I
Citation: Iv. Broek et al., Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor, BR J CANC, 85(9), 2001, pp. 1387-1395
Authors:
Rivera, E
Arrieta, O
Guevara, P
Duarte-Rojo, A
Sotelo, J
Citation: E. Rivera et al., AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma, BR J CANC, 85(9), 2001, pp. 1396-1399
Authors:
Alonso, MM
Encio, I
Martinez-Merino, V
Gil, M
Migliaccio, M
Citation: Mm. Alonso et al., New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells, BR J CANC, 85(9), 2001, pp. 1400-1402
Authors:
Liu, XM
Wang, LG
Kreis, W
Budman, DR
Adams, LM
Citation: Xm. Liu et al., Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells, BR J CANC, 85(9), 2001, pp. 1403-1411
Authors:
Cattan, I
Rochet, N
Mazeau, C
Zanghellini, E
Mari, B
Chauzy, C
de Novion, HS
Amiel, J
Lagrange, JL
Rossi, B
Gioanni, J
Citation: I. Cattan et al., Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors, BR J CANC, 85(9), 2001, pp. 1412-1417
Authors:
Wessel, N
Liestol, K
Maehlen, J
Brorson, SH
Citation: N. Wessel et al., The apolipoprotein E epsilon 4 allele is no risk factor for prostate cancer in the Norwegian population, BR J CANC, 85(9), 2001, pp. 1418-1418
Authors:
Anderson, H
Price, P
Blomley, M
Leach, MO
Workman, P
Citation: H. Anderson et al., Measuring changes in human tumour vasculature in response to therapy usingfunctional imaging techniques, BR J CANC, 85(8), 2001, pp. 1085-1093
Authors:
Blackhall, FH
Merry, CLR
Davies, EJ
Jayson, GC
Citation: Fh. Blackhall et al., Heparan sulfate proteoglycans and cancer, BR J CANC, 85(8), 2001, pp. 1094-1098
Authors:
de Wit, R
de Boer, AC
von der Linden, GHM
Stoter, G
Sparreboom, A
Verweij, J
Citation: R. De Wit et al., Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy, BR J CANC, 85(8), 2001, pp. 1099-1101
Authors:
Ball, HML
Hupp, TR
Ziyaie, D
Purdie, CA
Kernohan, NM
Thompson, AM
Citation: Hml. Ball et al., Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring, BR J CANC, 85(8), 2001, pp. 1102-1105
Authors:
Bottini, A
Berruti, A
Bersiga, A
Brizzi, MP
Bruzzi, P
Aguggini, S
Brunelli, A
Bolsi, A
Bolsi, G
Allevi, G
Generali, D
Betri, E
Bertoli, G
Alquati, P
Dogliotti, L
Citation: A. Bottini et al., Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer, BR J CANC, 85(8), 2001, pp. 1106-1112
Authors:
Ataman, OU
Bentzen, SM
Saunders, MI
Dische, S
Citation: Ou. Ataman et al., Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced nonsmall-cell lung cancer: A competing risks analysis, BR J CANC, 85(8), 2001, pp. 1113-1118
Authors:
Kasahara, T
Hara, N
Bilim, V
Tomita, Y
Saito, K
Obara, K
Takahashi, K
Citation: T. Kasahara et al., Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients, BR J CANC, 85(8), 2001, pp. 1119-1123
Authors:
Gelderblom, H
Sparreboom, A
de Jonge, MJA
Loos, WJ
Wilms, E
Mantel, MA
Hennis, B
Camlett, I
Verweij, J
van der Burg, MEL
Citation: H. Gelderblom et al., Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer, BR J CANC, 85(8), 2001, pp. 1124-1129
Authors:
Atzpodien, J
Kirchner, H
Illiger, HJ
Metzner, B
Ukena, D
Schott, H
Funke, PJ
Gramatzki, M
von Jurgensom, S
Wandert, T
Patzelt, T
Reitz, M
Citation: J. Atzpodien et al., IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastaticrenal cell carcinoma: long-term results of a controlled randomized clinical trial, BR J CANC, 85(8), 2001, pp. 1130-1136
Authors:
Choudry, GA
Stewart, PAH
Double, JA
Krul, MRL
Naylor, B
Flannigan, GM
Shah, TK
Brown, JE
Phillips, RM
Citation: Ga. Choudry et al., A novel strategy for NQO1 (NAD(P)H : quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9, BR J CANC, 85(8), 2001, pp. 1137-1146
Authors:
Baek, MJ
Kang, H
Kim, SE
Park, JH
Lee, JS
Paik, YK
Kim, H
Citation: Mj. Baek et al., Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability, BR J CANC, 85(8), 2001, pp. 1147-1152
Authors:
Andersson, S
Rylander, E
Strand, A
Sallstrom, J
Wilander, E
Citation: S. Andersson et al., The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas, BR J CANC, 85(8), 2001, pp. 1153-1156
Authors:
Riches, AC
Bryant, PE
Steel, CM
Gleig, A
Robertson, AJ
Preece, PE
Thompson, AM
Citation: Ac. Riches et al., Chromosomal radiosensitivity in G(2)-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics, BR J CANC, 85(8), 2001, pp. 1157-1161
Authors:
Wang, ZX
Wang, HY
Wu, MC
Citation: Zx. Wang et al., Identification and characterization of a novel human hepatocellular carcinoma-associated gene, BR J CANC, 85(8), 2001, pp. 1162-1167
Authors:
Muller-Tidow, C
Kugler, K
Diederichs, S
Klumpen, S
Moller, M
Vogt, U
Metzger, R
Schneider, PM
Berdel, WE
Serve, H
Citation: C. Muller-tidow et al., Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer, BR J CANC, 85(8), 2001, pp. 1168-1174
Authors:
Ding, S
Chamberlain, M
McLaren, A
Goh, LB
Duncan, I
Wolf, CR
Citation: S. Ding et al., Cross-talk between signalling pathways and the multidrug resistant proteinMDR-1, BR J CANC, 85(8), 2001, pp. 1175-1184
Authors:
Chio, CC
Wang, YS
Chen, YL
Lin, SJ
Yang, BC
Citation: Cc. Chio et al., Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice, BR J CANC, 85(8), 2001, pp. 1185-1192
Authors:
Kos, J
Sekirnik, A
Kopitar, G
Cimerman, N
Kayser, K
Stremmer, A
Fiehn, W
Werle, B
Citation: J. Kos et al., Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis, BR J CANC, 85(8), 2001, pp. 1193-1200
Authors:
Staff, S
Isola, JJ
Johannsson, O
Borg, A
Tanner, MM
Citation: S. Staff et al., Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa, BR J CANC, 85(8), 2001, pp. 1201-1205